Advertisement Fidelity
Home > Boards > US OTC > Medical - Drugs > Elite Pharmaceuticals (ELTP)

And, of course, different products, and just launched

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Drugdoctor Member Profile
Member Level 
Followed By 829
Posts 68,034
Boards Moderated 8
Alias Born 09/11/05
160x600 placeholder
Small Company Offering and Sale of Securities Without Registration (d) "Edgar (US Regulatory)" - 4/15/2014 1:40:11 PM
Securities Registration Statement (simplified Form) (s-3) "Edgar (US Regulatory)" - 4/15/2014 8:01:37 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/14/2014 8:01:13 AM
Elite Pharmaceuticals, Inc. Secures Funding Commitment of Up to $40 Million From Lincoln Park Capital Fund, LLC "GlobeNewswire Inc." - 4/14/2014 7:30:00 AM
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 4/3/2014 4:06:43 PM
Elite Pharmaceuticals Appoints Barbara Ellison as Vice President of Quality Operations and Regulatory Affairs "GlobeNewswire Inc." - 3/27/2014 12:15:05 PM
Elite Pharmaceuticals Announces Supplemental Application for Site Transfer of Isradipine "GlobeNewswire Inc." - 3/24/2014 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/18/2014 5:45:41 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/18/2014 5:39:00 PM
Annual Statement of Changes in Beneficial Ownership (5) "Edgar (US Regulatory)" - 3/18/2014 5:29:42 PM
Amended Statement of Beneficial Ownership (3/a) "Edgar (US Regulatory)" - 3/18/2014 5:18:03 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) "Edgar (US Regulatory)" - 3/18/2014 10:29:18 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/18/2014 6:32:13 AM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) "Edgar (US Regulatory)" - 3/18/2014 6:30:36 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/17/2014 6:10:11 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/17/2014 6:03:35 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/17/2014 5:58:21 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/17/2014 5:44:37 PM
Elite Pharmaceuticals Expands Abuse Deterrent Technology Patent Portfolio Internationally "GlobeNewswire Inc." - 3/10/2014 7:46:34 AM
Elite Pharmaceuticals Reports Successful Pivotal Bioequivalence Study for Abuse Deterrent Product ELI-200 "GlobeNewswire Inc." - 3/5/2014 7:30:00 AM
Statement of Beneficial Ownership (sc 13d) "Edgar (US Regulatory)" - 2/19/2014 4:50:00 PM
Elite Pharmaceuticals Reports Results of Pilot Bioequivalence Study for ELI-201 "GlobeNewswire Inc." - 2/18/2014 7:00:00 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) "Edgar (US Regulatory)" - 2/18/2014 6:23:58 AM
Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2014 "GlobeNewswire Inc." - 2/14/2014 9:49:40 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 2/14/2014 8:06:02 AM
Drugdoctor Member Level  Saturday, 06/09/12 10:31:47 PM
Re: dr_lowenstein post# 18518
Post # of 104673 
And, of course, different products, and just launched products, compared to established products that FDA pulled through no fault of ELTP's... But you know that... Yes, I see 50 million dollars annual revenues coming soon for ELTP! How nice is that?

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist